Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in children

被引:1
|
作者
Satirer, Oezlem [1 ,2 ]
Henes, Joerg C. [3 ,4 ]
Doering, Michaela [5 ]
Lesk, Till [6 ]
Benseler, Susanne [7 ,8 ]
Kuemmerle-Deschner, Jasmin Beate [1 ,2 ]
机构
[1] Univ Klinikum Tubingen, Dept Paediat, Tubingen, Baden Wurttembe, Germany
[2] Univ Klinikum Tubingen, Autoinflammat Reference Ctr Tuebingen arcT, Tubingen, Baden Wurttembe, Germany
[3] Univ Klinikum Tubingen, Ctr Interdisciplinary Clin Immunol Rheumatol & Aut, Tubingen, Baden Wurttembe, Germany
[4] Univ Klinikum Tubingen, Dept Internal Med Oncol Haematol Immunol & Rheumat, Tubingen, Baden Wurttembe, Germany
[5] Univ Tubingen, Pediat Hematol & Oncol, Tubingen, Baden Wurttembe, Germany
[6] Univ Klinikum Tubingen, Tubingen, Baden Wurttembe, Germany
[7] Alberta Childrens Hosp Res Inst, Rheumatol, Calgary, AB, Canada
[8] Childrens Hlth Ireland, Dublin, Ireland
来源
RMD OPEN | 2024年 / 10卷 / 03期
关键词
Treatment; Autoimmune Diseases; Hematopoietic Stem Cell Transplantation; JUVENILE IDIOPATHIC ARTHRITIS; CAR T-CELLS; SYSTEMIC-SCLEROSIS; ACTIVITY CRITERIA; INTERNATIONAL CONSENSUS; ETANERCEPT; GUIDELINES; BLOOD; IMMUNOTHERAPY; MULTICENTER;
D O I
10.1136/rmdopen-2024-004381
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To evaluate the long-term effectiveness and safety of autologous haematopoiesis stem cell transplantation (AHSCT) for severe, refractory autoimmune diseases in paediatric patients.Methods A single-centre study of consecutive children and adolescents with refractory autoimmune diseases undergoing AHSCT was performed. Demographics, clinical, laboratory features, pre-AHSCT medications, disease activity and functional status were captured. The primary outcome was progression-free survival, secondary outcomes included overall survival, disease-specific treatment responses, disease activity at the last follow-up and AHSCT safety.Results The study included seven patients: two systemic sclerosis, one pansclerotic morphoea, one eosinophilic fasciitis, one juvenile dermatomyositis and two patients with systemic juvenile idiopathic arthritis; four women, three men median age at AHSCT of 10 years (7-19), median follow-up post-AHSCT of 17 years. Median progression-free survival and overall survival was 4.2 years (95% CI: 0.98 to 8.3) and 17 years (95% CI: 11.8 to 22.1), respectively. Progression-free survival rates at 1 and 2 years post-AHSCT were 100% and 77%, respectively. All children survived. All patients are in clinical remission, only four require ongoing immunotherapy. Safety: Three experienced infections, including HHV6, Candida and Ralstonia sepsis; one developed a systemic inflammatory response syndrome; two new onset secondary autoimmune diseases including autoimmune haemolytic anaemia, Graves' disease and one was found to have a breast fibroadenoma. Treatment toxicity: one cyclophosphamide-associated transient renal failure and pericardial effusion, one patient with amenorrhoea/infertility.Conclusions AHSCT was an effective and safe approach for children and adolescents with treatment-refractory autoimmune diseases. The indication and timing of transplantation requires a careful consideration and a multidisciplinary approach.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [31] Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis
    Huang, Xianghua
    Chen, Wencui
    Ren, Guisheng
    Zhao, Liang
    Guo, Jinzhou
    Gong, Dehua
    Zeng, Caihong
    Hu, Weixin
    Liu, Zhihong
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (05): : 719 - 727
  • [32] Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells
    Oliver Rosen
    Andreas Thiel
    Gero Massenkeil
    Falk Hiepe
    Thomas Häupl
    Hartmut Radtke
    Gerd R Burmester
    Erika Gromnica-Ihle
    Andreas Radbruch
    Renate Arnold
    Arthritis Research & Therapy, 2
  • [33] Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells
    Rosen, O
    Thiel, A
    Massenkeil, G
    Hiepe, F
    Häupl, T
    Radtke, H
    Burmester, GR
    Gromnica-Ihle, E
    Radbruch, A
    Arnold, R
    ARTHRITIS RESEARCH, 2000, 2 (04) : 327 - 336
  • [34] New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis
    Burt, Richard K.
    Muraro, Paolo A.
    Farge, Dominique
    Oliveira, Maria Carolina
    Snowden, John A.
    Saccardi, Riccardo
    Han, Xiaoqiang
    Quigley, Kathleen
    Bueno, Valquiria
    Frasca, Daniela
    Fedorenko, Denis
    Burman, Joachim
    BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1509 - 1517
  • [35] Mobilization and conditioning protocols actualization for autologous stem cell transplantation for autoimmune diseases: Guidelines from MATHEC-SFGM-TC
    Bonnin, Agnes
    Terriou, Louis
    Beuvon, Clement
    Tudesq, Jean-Jacques
    Puyade, Mathieu
    Pugnet, Gregory
    Maria, Alexandre
    Llorente, Cristina Castilla
    Lansiaux, Pauline
    Cacciatore, Carlotta
    Badoglio, Manuela
    Yakoub-Agha, Ibrahim
    Farge-Bancel, Dominique
    Marjanovic, Zora
    BULLETIN DU CANCER, 2024, 111 (02) : S84 - S95
  • [36] An economic analysis of autologous hematopoietic stem cell transplantation (AHSCT) in the treatment of new onset type 1 diabetes
    Snarski, Emilian
    Szmurlo, Daria
    Halaburda, Kazimierz
    Krol, Malgorzata
    Urbanowska, Elzbieta
    Milczarczyk, Alicja
    Franek, Edward
    Wiktor-Jedrzejczak, Wieslaw
    ACTA DIABETOLOGICA, 2015, 52 (05) : 881 - 888
  • [37] Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn's Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD Low Intensity Therapy Evaluation Study Investigators
    Pockley, Alan Graham
    Lindsay, James O.
    Foulds, Gemma A.
    Rutella, Sergio
    Gribben, John G.
    Alexander, Tobias
    Snowden, John A.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [38] Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An Update
    Mariottini, Alice
    Bulgarini, Giovanni
    Cornacchini, Sara
    Damato, Valentina
    Saccardi, Riccardo
    Massacesi, Luca
    BIOENGINEERING-BASEL, 2023, 10 (02):
  • [39] Autologous stem cell transplantation: a possible treatment for refractory juvenile chronic arthritis?
    Wulffraat, NM
    Kuis, W
    RHEUMATOLOGY, 1999, 38 (08) : 764 - 766
  • [40] Stem cell transplantation in autoimmune diseases:: An update
    Jantunen, E
    Luosujärvi, R
    ANNALS OF MEDICINE, 2005, 37 (07) : 533 - 541